FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for unresectable advanced ...
Рет қаралды 222
Күн бұрынListen to a soundcast of the 9.17.2024 FDA approval of Keytruda (pembrolizumab) for unresectable advanced or metastatic malignant pleural mesothelioma.
U.S. Food and Drug Administration
Рет қаралды 984
FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory...
U.S. Food and Drug Administration
Рет қаралды 787
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic aci...
U.S. Food and Drug Administration
Рет қаралды 621
FDA D.I.S.C.O. Burst Edition: FDA approval of Bizengri (zenocutuzumab-zbco) for Treatment of adul...
U.S. Food and Drug Administration
Рет қаралды 408
U.S. Food and Drug Administration
Рет қаралды 1,5 М.
U.S. Food and Drug Administration
Рет қаралды 805
U.S. Food and Drug Administration
Рет қаралды 353
U.S. Food and Drug Administration
Рет қаралды 1,3 М.
U.S. Food and Drug Administration
Рет қаралды 2,1 М.
U.S. Food and Drug Administration
Рет қаралды 1,1 М.
U.S. Food and Drug Administration
Рет қаралды 756